Find Diphenhydramine Citrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

300 RELATED EXCIPIENT COMPANIES

494EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 88637-37-0, 2-(benzhydryloxy)-n,n-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate, Diphenhydramine citrate [usp], Diphenhydramine (citrate), 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid, 4od433s209
Molecular Formula
C23H29NO8
Molecular Weight
447.5  g/mol
InChI Key
SPCKHVPPRJWQRZ-UHFFFAOYSA-N
FDA UNII
4OD433S209

Diphenhydramine Citrate
A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.
1 2D Structure

Diphenhydramine Citrate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-benzhydryloxy-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid
2.1.2 InChI
InChI=1S/C17H21NO.C6H8O7/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-12,17H,13-14H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
2.1.3 InChI Key
SPCKHVPPRJWQRZ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
2.2 Other Identifiers
2.2.1 UNII
4OD433S209
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-diphenylmethoxy-n,n-dimethylethylamine

2. Allerdryl

3. Benadryl

4. Benhydramin

5. Benylin

6. Benzhydramine

7. Citrate, Diphenhydramine

8. Dimedrol

9. Diphenhydramine

10. Diphenhydramine Citrate (1:1)

11. Diphenhydramine Hydrochloride

12. Diphenylhydramin

13. Diphenylhydramine

14. Dormin

15. Hydrochloride, Diphenhydramine

2.3.2 Depositor-Supplied Synonyms

1. 88637-37-0

2. 2-(benzhydryloxy)-n,n-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate

3. Diphenhydramine Citrate [usp]

4. Diphenhydramine (citrate)

5. 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic Acid

6. 4od433s209

7. 2-(diphenylmethoxy)-n,n-dimethylethylamine Citrate (1:1)

8. Diphenhydramine Citrate (usp)

9. Ethanamine, 2-(diphenylmethoxy)-n,n-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)

10. Unii-4od433s209

11. Einecs 289-432-0

12. Schembl322306

13. Chembl1201089

14. Dtxsid80237211

15. Bcp12478

16. 2-(benzhydryloxy)-n,n-dimethylethanamine2-hydroxypropane-1,2,3-tricarboxylate

17. Akos016005048

18. Diphenhydramine Citrate [mart.]

19. Diphenhydramine Citrate [vandf]

20. 2-benzhydryloxy-n,n-dimethylethanamine,2-hydroxypropane-1,2,3-tricarboxylic Acid

21. Diphenhydramine Citrate [usp-rs]

22. Diphenhydramine Citrate [who-dd]

23. Diphenhydramine Citrate [orange Book]

24. D03854

25. Diphenhydramine Citrate [usp Monograph]

26. 637d370

27. Q5402419

28. (2-(diphenylmethoxy)ethyl)dimethylammonium Dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate

2.4 Create Date
2005-08-09
3 Chemical and Physical Properties
Molecular Weight 447.5 g/mol
Molecular Formula C23H29NO8
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count9
Rotatable Bond Count11
Exact Mass447.18931688 g/mol
Monoisotopic Mass447.18931688 g/mol
Topological Polar Surface Area145 Ų
Heavy Atom Count32
Formal Charge0
Complexity439
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Histamine H1 Antagonists

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)


Anesthetics, Local

Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)


Sleep Aids, Pharmaceutical

Drugs used to induce SLEEP, prevent SLEEPLESSNESS, or treat SLEEP INITIATION AND MAINTENANCE DISORDERS. (See all compounds classified as Sleep Aids, Pharmaceutical.)


Anti-Allergic Agents

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)


Antiemetics

Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)


Hypnotics and Sedatives

Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1681842600,"product":"BULK DRUG-DIPHENHYDRAMINE CITRATE USP 43","address":"A-201\/202, NAVBHARAT EST.,,ZAKARIA BUNDER RD.,SEWRI WEST,","city":"MUMBAI,MAHARASHTRA","supplier":"GEMINI EXPORTS","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"THE","customerCountry":"EGYPT","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"35","totalValueFC":"1488.6","currency":"USD","unitRateINR":2440,"date":"19-Apr-2023","totalValueINR":"122000","totalValueInUsd":"1488.6","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"9393935","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"A-201\/202, NAVBHARAT EST.,,ZAKARIA BUNDER RD.,SEWRI WEST,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1693506600,"product":"DIPHENHYDRAMINE CITRATE (INV.NO:92005509DT:23.08.2023)","address":"BSEL TECH PARK,B-WING,10TH FLR,SECTOR -30 A,OPP.VA","city":"STATION,VASHI,NAVI MUMBAI ,MAHARASH","supplier":"WANBURY LIMITED","supplierCountry":"INDIA","foreign_port":"SAN SALVADOR","customer":"TO THE ORDER OF","customerCountry":"EL SALVADOR","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"155","totalValueFC":"3578","currency":"USD","unitRateINR":11880,"date":"01-Sep-2023","totalValueINR":"297000","totalValueInUsd":"3578","indian_port":"Hyderabad Air","hs_no":"29214490","bill_no":"3645532","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EL SALVADOR","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"BSEL TECH PARK,B-WING,10TH FLR,SECTOR -30 A,OPP.VA, STATION,VASHI,NAVI MUMBAI ,MAHARASH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725388200,"product":"DIPHENHYDRAMINE CITRATE","address":"BSEL TECH PARK,B-WING,10TH FLR,SECTOR -30 A,OPP.VA","city":"STATION,VASHI,NAVI MUMBAI ,MAHARASH","supplier":"WANBURY LIMITED","supplierCountry":"INDIA","foreign_port":"TEL AVIV YAFO","customer":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","customerCountry":"ISRAEL","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"26","totalValueFC":"1031.3","currency":"USD","unitRateINR":2160.5999999999999,"date":"04-Sep-2024","totalValueINR":"86424","totalValueInUsd":"1031.3","indian_port":"Hyderabad Air","hs_no":"29214490","bill_no":"3755158","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"BSEL TECH PARK,B-WING,10TH FLR,SECTOR -30 A,OPP.VA, STATION,VASHI,NAVI MUMBAI ,MAHARASH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1730831400,"product":"DIPHENHYDRAMINE CITRATE(INV. NO:92006422DT:24.10.2024)","address":"BSEL TECH PARK,B-WING,10TH FLR,","city":"STATION,VASHI,NAVI MUMBAI ,MAHARASH","supplier":"WANBURY LIMITED","supplierCountry":"INDIA","foreign_port":"SAN SALVADOR","customer":"LABORATORIOS VIJOSA S.A.DE ","customerCountry":"EL SALVADOR","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"155","totalValueFC":"6882.1","currency":"USD","unitRateINR":11615.42,"date":"06-Nov-2024","totalValueINR":"580771","totalValueInUsd":"6882.1","indian_port":"Hyderabad Air","hs_no":"29214490","bill_no":"5385071","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EL SALVADOR","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"BSEL TECH PARK,B-WING,10TH FLR,, STATION,VASHI,NAVI MUMBAI ,MAHARASH","customerAddress":""},{"dataSource":"API Import","activeIngredients":"DIPHENHYDRAMINE CITRATE","year":"2021","qtr":"Q2","strtotime":1619289000,"product":"DIPHENHYDRAMINE CITRATE USP LOT NO: 1146625 DRUM LOCK: 0052548 PART NO. 24208","address":"PLOT NO.N- 39 AND PLOT NO. N- 39\/1, ADDITIONAL AMBERNATH MIDC, ANAND","city":"NAGAR,AMBERNATH(EAST) THANEH","supplier":"PERRIGO COMPANY PLC","supplierCountry":"UNITED STATES","foreign_port":"","customer":"PERRIGO COMPANY PLC","customerCountry":"INDIA","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"107.2","totalValueFC":"5482.5","currency":"USD","unitRateINR":"8163.3","date":"25-Apr-2021","totalValueINR":"408164","totalValueInUsd":"5482.5","indian_port":"BOMBAY AIR","hs_no":"29181520","bill_no":"3705755","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"","supplierAddress":"","customerAddress":"PLOT NO.N- 39 AND PLOT NO. N- 39\/1, ADDITIONAL AMBERNATH MIDC, ANAND"}]
25-Apr-2021
06-Nov-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Direct Compression

read-more
read-more

Controlled & Modified Release

read-more
read-more

Granulation

read-more
read-more

Solubilizers

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Topical

read-more
read-more

Co-Processed Excipients

read-more
read-more

Parenteral

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Coloring Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Empty Capsules

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Diphenhydramine Citrate Manufacturers

A Diphenhydramine Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diphenhydramine Citrate, including repackagers and relabelers. The FDA regulates Diphenhydramine Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diphenhydramine Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Diphenhydramine Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Diphenhydramine Citrate Suppliers

A Diphenhydramine Citrate supplier is an individual or a company that provides Diphenhydramine Citrate active pharmaceutical ingredient (API) or Diphenhydramine Citrate finished formulations upon request. The Diphenhydramine Citrate suppliers may include Diphenhydramine Citrate API manufacturers, exporters, distributors and traders.

click here to find a list of Diphenhydramine Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Diphenhydramine Citrate USDMF

A Diphenhydramine Citrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Diphenhydramine Citrate active pharmaceutical ingredient (API) in detail. Different forms of Diphenhydramine Citrate DMFs exist exist since differing nations have different regulations, such as Diphenhydramine Citrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Diphenhydramine Citrate DMF submitted to regulatory agencies in the US is known as a USDMF. Diphenhydramine Citrate USDMF includes data on Diphenhydramine Citrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diphenhydramine Citrate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Diphenhydramine Citrate suppliers with USDMF on PharmaCompass.

Diphenhydramine Citrate WC

A Diphenhydramine Citrate written confirmation (Diphenhydramine Citrate WC) is an official document issued by a regulatory agency to a Diphenhydramine Citrate manufacturer, verifying that the manufacturing facility of a Diphenhydramine Citrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Diphenhydramine Citrate APIs or Diphenhydramine Citrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Diphenhydramine Citrate WC (written confirmation) as part of the regulatory process.

click here to find a list of Diphenhydramine Citrate suppliers with Written Confirmation (WC) on PharmaCompass.

Diphenhydramine Citrate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diphenhydramine Citrate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Diphenhydramine Citrate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Diphenhydramine Citrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Diphenhydramine Citrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diphenhydramine Citrate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Diphenhydramine Citrate suppliers with NDC on PharmaCompass.

Diphenhydramine Citrate GMP

Diphenhydramine Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Diphenhydramine Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diphenhydramine Citrate GMP manufacturer or Diphenhydramine Citrate GMP API supplier for your needs.

Diphenhydramine Citrate CoA

A Diphenhydramine Citrate CoA (Certificate of Analysis) is a formal document that attests to Diphenhydramine Citrate's compliance with Diphenhydramine Citrate specifications and serves as a tool for batch-level quality control.

Diphenhydramine Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Diphenhydramine Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Diphenhydramine Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Diphenhydramine Citrate EP), Diphenhydramine Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diphenhydramine Citrate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty